ARCA biopharma, Inc. (NasdaqCM:ABIO) is seeking acquisitions. ARCA announced an equity offering with an offering price of up to $7.3 million. It may also use a portion of the net proceeds to invest in or acquire businesses or technologies that we believe are complementary to our own, although we have no current plans, commitments or agreements with respect to any acquisitions as of the date of this prospectus.